Gynecological infection

Povidone iodine, also known as iodopovidone, excellent-iodine, and Puweilong iodine, is a broad-spectrum antibacterial agent. Povidone iodine is widely used in medicine for surgical scrubbing, skin cleaning before and after surgery, prevention and treatment of infected wounds, ulcers, cuts, burns, bedsores and congestion ulcers, gynecological vaginitis, candida, trichomonas or mixed infections. The following is a brief introduction to povidone iodine solution how to use. Povidone iodine solution how to use? Currently, there are many preparations of different dosage forms and concentrations on the market. When using, pay attention to the use of each preparation:   1. 10% povidone iodine solution is a solution used for skin wound disinfection. It does not need to be diluted when used. Apply the disinfectant directly to the damaged skin. It should be applied within 3-5cm around the lesion and applied twice a day. If necessary, the wound can be covered with sterile gauze to avoid infection.   2. 1% povidone iodine solution is used for gargling and mouthwashing. It is suitable for oral bacterial infections, pharyngitis, tonsillitis and other conditions. When using, the solution can be used to gargle directly without dilution or dilute with warm water. Each dosage is about 10ml, gargle for 30 seconds, do not swallow, and use 2-4 times a day. Note that it should not be used for more than 14 days and is only limited to adults and children over 6 years old.   3. For dry powder spray 2.5%, shake the bottle before use, spray the medicine on the affected area 15-20cm away from the affected area until the foam covers the wound. If necessary, cover the wound with sterile gauze. Be careful not to spray into the mucosal cavity. It is limited to skin lesions. It is only for adults and children over 2 years old. Pregnant and lactating women should use it with caution.   4. For povidone iodine solution10% ointment, this dosage form is an external agent, apply it to the wound, and then cover it with sterile gauze.   5. Povidone iodine vaginal douche 10% is used to douche the vulva and assist in the treatment of gynecological inflammatory diseases, excessive leucorrhea, vaginitis, and cervicitis. Dilute about 10 ml of the solution with 1 liter of clean water and soak the private parts. After the symptoms disappear, stop douche and do not use it for a long time.   In addition to understanding povidone iodine solution how to use, we should also pay attention to the fact that it may bring some side effects, including skin irritation. If applied to large wounds, people with poor renal function may cause hypernatremia and metabolic acidosis. It is not recommended for people who are less than 32 weeks pregnant or taking lithium salts. People with thyroid problems are advised not to use it frequently.   In short, povidone iodine solution how to use is something you need to fully understand before treating the disease. Although there are few side effects, people need to strictly follow the drug instructions and doctor's advice when using povidone iodine.

Povidone iodine, also known as iodopovidone, excellent-iodine, and Puweilong iodine, is a broad-spectrum antibacterial agent. Povidone iodine solution first aid antiseptic is a type of iodine tincture, used for skin disinfection and sterilization before and after surgery, prevention and treatment of local wound infections, and first aid for minor cuts, abrasions, burns, and blisters. Povidone iodine solution first aid antiseptic is a polyvidone chemical polymer and iodine element, containing 9% to 12% iodine. Its mechanism of action is the death of microorganisms caused by the release of iodine. It has a wide range of antibacterial activity and has a killing effect on bacteria, fungi, protozoa, and viruses. This is an over-the-counter drug. Povidone iodine entered commercial use in 1955 and is one of the World Health Organization's essential medicines list and the most important drug in the basic health system. In the solution, the iodine element in povidone iodine is slowly released, and it has been proven that bacteria do not develop resistance to povidone iodine, and the human sensitization rate is only 0.7%. Therefore, povidone iodine is widely used in medicine, for surgical scrubbing, skin cleaning before and after surgery, prevention and treatment of infected wounds, ulcers, cuts, burns, bedsore infections and treatment of congestive ulcers, gynecological vaginitis, candida, trichomoniasis or mixed infections. How to use povidone iodine solution first aid antiseptic？ - For external use, dip a small amount with a cotton swab and apply topically from the center to the periphery, 1-2 times a day. - Surgical disinfection: scrub with 0.5% solution for 5 minutes. Disinfection of injection site, more than 30 seconds. - Disinfection of surgical field skin: Apply 0.5% solution evenly twice. - Mucosal trauma or infection: rinse with 0.1%~0.025% solution. - Skin infection: Apply 0.5% solution topically. Povidone iodine solution first aid antiseptic side effects may include skin irritation. If applied to large wounds, people with poor renal function may develop hypernatremia and metabolic acidosis. It is not recommended for people who are less than 32 weeks pregnant or taking lithium salts. People with thyroid problems are advised not to use it frequently.

Funding to support development of point-of-care diagnostic platform for women's health CAMBRIDGE, Mass., May 21, 2024 /PRNewswire/ -- Nanopath Inc., a point-of-care diagnostics company enabling high-quality molecular testing in minutes, announced today that it was awarded $4 million in federal funding. The company was awarded a $3 million grant from the National Institutes of Health (NIH) and a $1 million grant from the National Science Foundation (NSF) to support continued research and development of the company's point-of-care diagnostic platform for pelvic and gynecologic infections. Both grants were awarded through the Small Business Innovation Research (SBIR) Program, a competitive, awards-based program designed to stimulate technological innovations developed by small businesses. These grants bring the company's total funding to over $15 million. It is well documented that women's health is underfunded and under-researched. Nanopath is working to tackle these health disparities through development of a novel diagnostic technology that is intentionally designed to meet the needs of women, empowering them to take control of their health. The company's low-cost, easy-to-use diagnostic platform is designed to provide unparalleled access to clinically actionable molecular diagnostic information at the point-of-care. Nanopath will use the new funds towards core platform development, including the test consumable and readout instrumentation, as well as analytical and clinical validation of their lead assay. The company envisions that the technology could become the new standard of care for characterization of pelvic and gynecologic infections. "This funding is a tremendous vote of confidence in Nanopath's ability to transform molecular diagnostics and enable providers to move away from the traditional view of disease-specific diagnostic testing, and towards patient-centric testing," said Amogha Tadimety, Ph.D., co-founder and CEO of Nanopath. "The outcomes of this grant-funded work could lay the groundwork for a new era of clinically informative diagnostics at any site-of-care, changing the paradigm of women's healthcare." Nanopath has developed advanced prototypes of both its disposable test cartridge and benchtop readout instrument and is actively developing its pipeline of test offerings through clinical collaborations with preeminent hospitals in New England. "The groundbreaking data, workflows and prototypes developed by our team over the last year formed the foundation of our applications for both grants," said Alison Burklund, Ph.D., co-founder, President, and CTO of Nanopath. "Nanopath is commercializing a novel technology that has never before been used for molecular diagnostics. Support from NSF, NIH, and the broader scientific community will catalyze our commercial development." Since the company raised a $10 million Series A in 2022, Nanopath has hit several significant milestones, including: growing the team from 4 to 14 employees, receiving the 2022 American Association Diagnostic and Laboratory Medicine (ADLM) Disruptive Technology Award, and recognition of its co-founder on the 2023 Forbes 30 Under 30 (Healthcare) list. Nanopath also introduced its Scientific Advisory Board, comprised of several influential scientists in the field of nanobiosensing. About Nanopath Nanopath is dedicated to improving health equity worldwide, starting with women's health. Nanopath's proprietary molecular diagnostic testing platform takes a radically new approach to how clinicians characterize human health. The company's novel biosensing technology has the potential to enable fast, high-complexity testing at the point-of-care, rather than in centralized laboratories. The Nanopath team is deeply passionate about improving the lives of women and other underserved populations through equitable application of novel technology. The company is headquartered in Cambridge, Mass., at The Engine built by MIT, a premier facility for high-potential, tough-tech start-ups. Nanopath is backed by Norwest Venture Partners, the Medtech Convergence Fund (an SV Health Investors fund), Gingerbread Capital and Green D Ventures. For more information, visit .